| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Ocriplasmin |
| Brand | Jetrea® |
| Indication | For the treatment of vitreomacular traction (VMT), including when associated with macular hole of diameter less than or equal to 400 microns. |
| Assessment Process | |
| Rapid review commissioned | 12/06/2013 |
| Rapid review completed | 09/07/2013 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |